IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Evaxion Biotech A/S

Q3 2025 vs Q1 2026

Comparing institutional holders between quarters

Quarters

Q1 2026Q3 2025Q2 2025Q1 2025Q4 2024
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile
Merck & Co., Inc.
UNCHANGED
Shares1,214,126 from 1,214,126
Change0 (0%)
Value$4.5M (-$48.6K)
Filed 2026-05-13
Rhumbline Advisers
CLOSED
Shares0 from 2
Change-2 (-100%)
Value$0 (-$7)
Filed 2026-05-12
Status
Merck & Co., Inc.
UNCHANGED1,214,1261,214,12600%$4.6M$4.5M-$48.6K2026-05-13
Rhumbline Advisers
CLOSED02-2-100%$7$0-$72026-05-12
Showing 2 of 2 institutions